Titration of Lantus (Insulin Glargine) for Diabetes
For patients with type 2 diabetes not currently on insulin, start Lantus at 10 units once daily (or 0.2 units/kg), then increase by 2 units every 3 days until fasting plasma glucose reaches <7.0 mmol/L (<126 mg/dL) without hypoglycemia. 1, 2
Starting Dose
Type 2 Diabetes (Insulin-Naive)
- 10 units once daily OR 0.2 units/kg once daily 2
- Administer at the same time each day (any time, but consistency is key) 2
Type 1 Diabetes
- Start at approximately one-third of total daily insulin requirements 2
- The remaining two-thirds should come from short-acting premeal insulin 2
Converting from NPH Insulin
- From once-daily NPH: Use the same dose unit-for-unit 2
- From twice-daily NPH: Use 80% of the total NPH dose to reduce hypoglycemia risk 1, 2
Titration Algorithm
The evidence-based approach endorsed by the 2025 ADA Standards of Care is straightforward:
- Set fasting plasma glucose (FPG) goal: <7.0 mmol/L (<126 mg/dL) 1
- Increase by 2 units every 3 days until FPG goal is reached without hypoglycemia 1
- For hypoglycemia: Determine the cause; if no clear reason exists, reduce dose by 10-20% 1
This is the guideline-recommended standard. The FDA label for Lantus aligns with this approach, emphasizing individualized dosing based on blood glucose monitoring 2.
Alternative Patient-Preferred Titration
Recent research suggests a patient-preferred algorithm may achieve faster glucose control with better adherence: increase by 1 unit daily if same-day FPG ≥7.0 mmol/L 3. This 2024 study showed:
- Higher cumulative rates of achieving FPG targets (100% vs 88.1% at week 4, p=0.036) 3
- Significantly better adherence (97.4% vs 66.7%, p<0.001) 3
- No increase in hypoglycemia 3
However, the guideline-recommended 2 units every 3 days remains the standard of care 1, as it is explicitly endorsed by the 2025 ADA Standards and FDA labeling 2.
Monitoring and Adjustment
- Reassess every 3-6 months to avoid therapeutic inertia 1
- Monitor for signs of overbasalization: elevated bedtime-to-morning glucose differential, postprandial-to-preprandial differential, hypoglycemia (aware or unaware), or high glucose variability 1
- If A1C remains above goal despite adequate basal insulin, consider adding GLP-1 receptor agonist or prandial insulin rather than continuing to increase basal insulin 1
Special Populations
Hospitalized Patients with Mild Hyperglycemia
- For blood glucose <200 mg/dL in insulin-naive patients: Consider starting at 0.1 units/kg per day 4
Hospitalized Patients with Moderate Hyperglycemia
- For blood glucose 201-300 mg/dL: Start at 0.2-0.3 units/kg per day 4
Patients at High Risk for Hypoglycemia
- Frail, elderly, or those with acute kidney injury: Reduce starting dose to 0.15 units/kg per day 4
Common Pitfalls to Avoid
- Therapeutic inertia: Failing to titrate regularly leads to prolonged hyperglycemia. Reassess every 3-6 months 1
- Overbasalization: Continuing to increase basal insulin when A1C remains elevated despite adequate fasting glucose control. Look for elevated postprandial glucose as a signal to add prandial coverage instead 1
- Inadequate hypoglycemia response: Always reduce dose by 10-20% if hypoglycemia occurs without clear cause 1
- Inconsistent timing: Lantus must be given at the same time daily for optimal effect 2